510(k) device
DeepRESP
Nox Medical Ehf · Automatic Event Detection Software For Polysomnograph With Electroencephalograph (OLZ, Class II) · First FDA decision Mar 14, 2025, newest Nov 17, 2025Sleep apnea
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "DeepRESP"
MAUDE reports
0
Brand "DeepRESP", since 2015
PubMed studies
2
Mentioning "DeepRESP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing DeepRESP
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- DeepRESP510(k)
K252330 · Decided Nov 17, 2025 · 115 days after receipt
Device type: Automatic Event Detection Software For Polysomnograph With Electroencephalograph (OLZ) · Neurology & Neurosurgery
- DeepRESP510(k)
K241960 · Decided Mar 14, 2025 · 254 days after receipt
Device type: Automatic Event Detection Software For Polysomnograph With Electroencephalograph (OLZ) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "DeepRESP", any status and sponsor, newest update first.
No registered device study names "DeepRESP".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "DeepRESP", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OLZ
10 reports: 8 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "DeepRESP"[tiab]. The summary above synthesizes these.
- Validation of a deep learning-based system for sleep staging, arousal detection, and respiratory event scoring in atrial fibrillation patients.
Sousa S, Teixeira C, Sigmarsdóttir T, et al. · J Clin Sleep Med · 2026Validation Study
- DeepResp: Deep learning solution for respiration-induced B0 fluctuation artifacts in multi-slice GRE.
An H, Shin HG, Ji S, et al. · Neuroimage · 2021Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code OLZ.
- Sleep ProfilerAdvanced Brain Monitoring, Inc. · 510(k) 2016
- Somnum (Somnum)Honeynaps Co., Ltd. · 510(k) 2026
- Dreem 3SBeacon Biosignals, Inc. · 510(k) 2024
- EnsoSleepEnsodata, Inc. · 510(k) 2021
- Sleepware G3Respironics, Inc. · 510(k) 2020
- Sleep Analysis ModuleNeurotronics, LLC · 510(k) 2026
- Onera SleepMap (SLEEPMAP)Onera B.V. · 510(k) 2026
- Hypnos (369054-200)Cadwell Industries, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.